Inopase
Manufacturing · Australia · 11-50 Employees
View Company Info for Free
Overview
Headquarters
27/328 Reserve Rd, Cheltenham, Victoria,...Website
www.inopase.comRevenue
<$5 MillionIndustry
About Inopase
Inopase Org Chart
Is Inopase your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Inopase, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Inopase
Check out if Inopase is spiking on competitors!
Click to see if Inopase had a recent Job posting/layoffs
Check if Inopase has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Inopase recently announced quarterly report
Funding: Get notified immidiatlly once Inopase has new funding data
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Inopase launches new products
Recommended Actions
Find VP level buyers at Inopase
Find 3 more new buyers
Company Profile Activity
Activity Insights
Inopase is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Inopase is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Inopase.
Inopase Tech Stack
A closer look at the technologies used by Inopase
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Inopase
INOPASE is an innovative medical device company focused on providing advanced solutions for chronic neurological diseases through personalized, wireless-powered closed-loop neuromodulation. Their technology enhances symptom management and improves the quality of life for patients suffering from conditions such as drug-resistant epilepsy and overact... Read More